FSLR has dropped 5.1% this week and 10.3% over the past month, closing at $202.34 — and the options market is now more defensive than it has been in months.
The clearest signal right now is in options. The put/call ratio has climbed to 0.70, more than two standard deviations above its 20-day mean of 0.66 — the most elevated defensive reading in recent memory. That z-score of 2.11 reflects genuine hedging demand rather than routine positioning, and it has been building steadily since mid-August when the PCR sat closer to 0.58. The borrow market, by contrast, remains completely uncrowded. Availability is running near 754% — meaning there are roughly seven and a half shares available to borrow for every one already out on loan. That is loose by any measure, and it has actually eased over the past week. Cost to borrow has nudged up 8% on the week to 0.58%, and is 36% above its August lows, but in absolute terms it remains very cheap. Short interest has been trimming too. At 8.7% of free float, it is down 4.5% on the week and 12% from a month ago — a meaningful retreat from the ~10.7% peak seen in mid-August. The picture that emerges is one where equity investors are buying protection, but dedicated short sellers are actually reducing exposure. Caution, not conviction, describes the positioning.
The Street is broadly constructive, which makes this week's slide a tension worth examining. Morgan Stanley raised its target to $323 in mid-August and still rates the stock Overweight. Wells Fargo is at $313, Citigroup at $297, Deutsche Bank at $299. Piper Sandler just initiated coverage this week at Overweight with a $260 target. The consensus sits at Buy, with the mean target around $275 — implying roughly 36% upside to Tuesday's close. The one dissenting voice is Evercore ISI, which trimmed its target fractionally to $218, consistent with its In-Line rating. That analyst divergence is visible in the factor scores: FSLR ranks in the 96th percentile on analyst recommendation differential — meaning the gap between its actual rating and the broader analyst universe is unusually wide in the bullish direction. Valuation is notably undemanding too. The trailing P/E has compressed to 9.6x and EV/EBITDA to 6.5x, both drifting lower over 30 days. The bull case rests on thin-film technology leadership, a strong production footprint, and positioning ahead of domestic demand growth. The bear case focuses on potential US market oversupply, emerging perovskite competition, and residual reliance on Chinese equipment.
The activist register carries one noteworthy flag. Farhad Fred Ebrahimi filed a Schedule 13D/A in March 2025, disclosing a stake then at approximately 4.95% — that 13D designation signals active intent rather than passive ownership. His position is as-last-disclosed and he could have moved below the 5% threshold since without a further filing. More recently in the institutional register, Capital Research and Management added over 3.7 million shares in its latest reported period to reach 3.83% of shares — a significant build. BlackRock, State Street, and Geode all added modestly too. On the insider side, the 90-day net is a sell of around $3.6 million in value, driven mainly by the CTO and General Counsel disposing of shares under pre-arranged 10b5-1 plans. Planned sales under 10b5-1 carry far less informational content than discretionary transactions, so this flow reads as routine compensation mechanics rather than a directional signal.
The earnings calendar gives this setup a concrete focus. Q3 results are scheduled for October 27. The last print, in late July, delivered a 5.9% one-day gain and a 22.5% five-day move — a strong post-earnings tailwind. The prior quarter produced a softer day-one reaction of -3.2% before recovering sharply over the following week. The short score has drifted down from around 55 earlier in the week to 52.3, consistent with shorts trimming into weakness rather than adding into it. What to watch heading into late October is whether the options put/call ratio continues climbing above its recent range — and whether any of the bullish Street targets, now sitting well above the current price, attract incremental conviction from here.
See the live data behind this article on ORTEX.
Open FSLR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
